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Recanalization of totally occluded iliac and
adjacent venous segments
Seshadri Raju, MD, Susan McAllister, PhD, and Peter Neglen, MD, PhD, Jackson, Miss
Purpose: The purpose of this study was to report our experience with percutaneous recanalization of totally occluded iliac
veins and inferior vena cava.
Material and Methods: Recanalization of the iliac vein was performed in 38 limbs. In nine limbs, recanalization of the
inferior vena cava was also necessary (two with filter). In 28 of 38 limbs, the stent was extended below the groin crease
into the common femoral vein segment. Large-caliber (14 or 16 mm for iliac vein) flexible self-expanding stents were
used. Stents were routinely extended for a short distance into the inferior vena cava to forestall development of iliocaval
stenosis. Intravascular ultrasound scan was a valuable tool in the procedure. The median length of the recanalized
segment was long (22 cm), and multiple stents (median, n 3) were necessary in most patients. Forty-five percent of the
patients had coagulation abnormalities.
Results: No morbidity or mortality was seen. Actuarial primary, primary assisted, and secondary patency rates of the stents
at 24 months were 49%, 62%, and 76%, respectively. Median pain level decreased significantly (level 4 to level 0; P <
.0001) after stent placement, and more than two thirds of the patients became totally pain free after the procedure.
Swelling also improved significantly, and a third of the patients became totally free of any swelling after stent placement.
Sixty-six percent of cases with stasis ulcers/dermatitis (n  14) were resolved (actuarial, 1 year), although uncorrected
reflux persisted in many of these limbs.
Conclusion: Percutaneous recanalization of the occluded iliac vein with stent placement appears to be successful in the
short term, with good patency, significant symptom resolution, and minimal morbidity. (J Vasc Surg 2002;36:903-11.)
Stenotic lesions of the iliac venous segment can be
successfully treated with percutaneous balloon dilation and
stent placement.1 Excellent short-term patency and clinical
efficacy rates have been reported.2 This report describes our
experience with recanalization of totally occluded iliac veins
and adjoining venous segments with the percutaneous bal-
loon/stent technique.
MATERIAL AND METHODS
Recanalization was performed in 38 postthrombotic
limbs in 38 patients from July 1997 to October 2001. In
two patients, bilateral stent placement was carried out to
recanalize an ipsilateral iliac venous segment and correct a
stenotic but nonoccluded lesion in the contralateral iliac
venous segment as well. In nine patients, the adjoining
inferior vena cava, which was occluded (two with filters) in
continuity with the iliac venous segment, was recanalized
also. In 28 limbs, the stent was extended below the inguinal
ligament to correct occlusion/stenosis of the common
femoral vein segment in continuity with the occluded iliac
vein. Median age was 44 years (range, 27 to 81 years), the
left/right ratio was 5/3, and the female/male ratio was
3/1.
Most limbs (88%) had significant additional veno-
graphic postthrombotic changes (diffuse narrowing, tra-
beculae, or occlusions) in the distal venous tree; in only 12%
did the main iliac or iliofemoral occlusion appear to be
isolated with “normal” appearing veins below the lesion.
Distal postthrombotic changes were typically diffuse and
extensive, involving all three distal axial venous segments
(superficial femoral, popliteal, posterior tibial) in 62%, two
segments in 29%, and a single segment in only 9%. The
profunda femoris vein showed venographic postthrom-
botic changes in 42% of limbs treated, and when this
condition occurred, it was exclusively associated with mul-
tisegment distal postthrombotic changes.
Separate from the main iliac or iliofemoral occlusion,
additional tandem total occlusions in the superficial femo-
ral, popliteal, or posterior tibial veins were present in 52% of
limbs. Seventy-seven percent of such tandem occlusions
involved only one distal venous segment and most com-
monly occurred (70%) in the superficial femoral vein. Distal
tandem occlusions were not recanalized.
Reflux with duplex scan examination was present in
87% of the ipsilateral extremities, and in only 13% was no
reflux seen. When present, reflux was confined to the
superficial venous system alone in 12%, the deep system
alone in 23%, and both the superficial and deep systems in
the remaining 65% of involved limbs. Reflux was not cor-
rected in the recanalized limbs.
Clinical evaluation. All patients had various combi-
nations of leg pain, swelling, and skin changes (Table I).
The median duration of symptoms at presentation was 7
years (range, 2 months to 40 years). CEAP classification3 of
the clinical material was as follows: C0, n  3 (pain only
symptom); C3, n 19; C4, n 2; C5, n 0; and C6, n
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14, with active ulcers present. Pain, often severe, was a
common form of primary presentation. Pain was present in
89% of the limbs.
The level of pain was measured with the visual analogue
scale method.4 A commonly available plastic tape measure
with markings on only one side trimmed to 10 cm in length
was used. The patient was asked to indicate the pain level on
the unmarked side of the device, with one end representing
no pain and the other extreme pain. The indicated pain
level could then be translated into numeric grade (0 to 10)
by the examiner with referral to the scale markings on the
side hidden to the patient. Patients were asked to fill out a
quality of life questionnaire5 validated for assessment of
chronic venous insufficiency prospectively before recanali-
zation and again at each subsequent postoperative visit.
Numerical grades (1 to 5) were provided for each question,
allowing the patient to assign a numeric value to the an-
swers. The last available response was used in postoperative
outcome analysis. Swelling was graded with physical exam-
ination as follows: grade 0, none; grade 1, pitting, not
obvious; grade 2, ankle edema; and grade 3, obvious swell-
ing involving the limb.
Preoperative assessment. Preoperative assessment
included hypercoagulation studies, extensive hemody-
namic and duplex scan examination (Table II), and contrast
ascending and transfemoral venography. Foot swelling or
extension of the occlusive lesion to the femoral venous
segment precluded one or more of these studies in some
patients. In such cases, contralateral femoral approach was
attempted to define the occlusive lesion.
Intraoperative functional assessment. Base femoral
venous pressure, pressure gradient, and increase in femoral
vein pressure in response to 30 mg of papaverine hydro-
chloride injected into the adjoining femoral artery6 with
ultrasound scan guidance were measured before and after
recanalization.
Postoperative assessment. Postoperative assessment
included clinical evaluation (at 6 weeks and 3-month to
6-month intervals thereafter), transfemoral or ascending
venogram (latter in case of infrainguinal stent extension) to
assess stent patency, duplex scan, and venous functional
studies (at 6 weeks and yearly thereafter; sooner if war-
ranted by clinical deterioration). Intravascular ultrasound
scan (IVUS) was often combined with transfemoral venog-
raphy when secondary interventions were anticipated.
Technique. The procedure was performed in an en-
dovascular surgical suite. General anesthesia was preferred
because the recanalization process was often painful and
sometimes prolonged; it provided superior comfort and
safety, particularly in elderly patients with diminished car-
diopulmonary reserve. Ipsilateral percutaneous femoral
vein access through a 9F sheath after needle exchange over
guidewire (Glidewire, Terumo Medical, Ann Arbor, Mich;
0.035 in) was obtained with ultrasound scan guidance (Fig
1). Thigh access was more convenient and allowed better
maneuverability of instrumentation through the occlusion
than the popliteal approach. Use of a stiff guidewire and
predilation with serial dilators facilitated sheath placement
in case of perivenous fibrosis. Puncture site hematoma/
bleeding after sheath removal has not been a problem
(common in arterial access) because of the relatively low
pressure on the venous side and the routine use of tampon-
ade devices (Vasoseal, Datascope Corp, Montvale, NJ).
An initial contrast study and a “road map” were used to
manipulate the guidewire beyond the point of occlusion.
Guidewire manipulation was by both sight (road map) and
feel; as the guidewire progressed, repeat contrast studies
were obtained as necessary, with sensitivity to the total
amount of contrast used. A combination of soft and stiff
Glidewires with straight, angled, and “J” tips and differing
sizes (0.016 in to 0.035 in) with supporting catheters
(straight or angled) were often necessary for successful
passage of the occluded segments. Once the correct plane
was entered, rapid progress without perforation could be
obtained with development of a loop or extended J at end
of a stiff guidewire during manipulation. Whenever a per-
foration was detected with free lateral movement of the
guidewire tip or contrast extravasation, the procedure was
terminated and attempted again 3 to 4 weeks later. If
difficulty was encountered in onward passage, manipula-
tion of the guidewire through a collateral running parallel
to the occluded segment could be attempted. Passage
through the occluded iliocaval junction usually met with
additional resistance that necessitated extended manipula-
tion in the area with coaxial catheter support. Specialized
techniques, such as those described to cross the occluded
aortoiliac junction, were not used.7
Successful vena cava entry was indicated by further easy
passage of the guidewire into the right atrium and was
confirmed with IVUS or contrast injection. Serial progres-
sive dilations to 16 mm for the distal cava and common iliac
veins, to 14 mm for the external iliac vein, and 12 mm for
the common femoral vein were chosen for most cases.
Extension of the stent into the distal vena cava for 2 to 3 cm
or even longer as determined with IVUS was routine to
avoid later stenotic development in this area.8 Skip areas of
less than 4 cm in length between stents were avoided even
if this segment was patent because stenotic lesions tended
to occur later in these areas as well. All diseased or occluded
segments were covered, going below the inguinal ligament
if necessary. The profunda femoris vein was easily identified
with IVUS, and extension of the stent across the groin
crease into the common femoral vein just above the pro-
funda orifice was not found to jeopardize stent patency; on
the contrary, failure to support the diseased common fem-
Table I. Presenting symptoms in 38 limbs with iliac vein
occlusion
Symptom/combination No.
Pain only 3
Swelling only 5
Pain and swelling 14
Ulcer/stasis skin changes only 12
Pain and stasis skin changes/ulcer 2
Pain, swelling, and stasis skin changes/ulcer 2
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oral segment with a stent resulted in thrombosis of the stent
from poor inflow.
Stent deployment was mandatory in treatment of ve-
nous stenosis because balloon dilatation alone resulted in
invariable recoil9 and restenosis. We did not place stents in
the superficial femoral vein because the profunda femoris
appeared to provide adequate inflow. Self-expanding stents
(Wallstent, Boston Scientific, Natick, Mass) were used ex-
clusively. The lengths of the individual stents were chosen
to minimize the overall number of stents deployed, allow-
ing for a generous overlap of 3 to 4 cm between stents to
avoid stent separation during postdeployment dilation.
Proximal migration of the stent crossing the tight iliocaval
junction could occur during this phase if adequate predila-
tion with oversized balloons when necessary was not
achieved. “Shelving” between stents of different sizes (eg,
Fig 1. Femoral vein access is obtained as low as possible in thigh. With access at higher levels, sheath length should be
kept to minimum to allow stent delivery into common femoral vein if desired. Ultrasound scan guidance is necessary
because vessels are deep and vein has variable relationship to artery depending on level of entry. When superficial
femoral vein is occluded, profunda femoris or deep thigh collateral may be accessed.
Table II. Functional studies before and after recanalization and stent placement
Test
Present Poststent
No.
Median
(range) No.
Median
(range)
Intraoperative pressure measurements
Femoral base pressure (mm Hg) 31 12 (3-27) 30 10 (3-21)†
Pressure gradient (mm Hg) 27 2 (5-9) 26 0 (0-84)†
Pressure increase with intraarterial
papavarin (mm Hg)6
28 3 (1-14) 29 0 (1-10)‡
Postoperative tests
Ambulatory venous pressure
Percent drop (mm Hg) 30 60 (30-93) 16 60 (24-97)*
VFT (seconds) 31 18 (3-136) 14 21 (5-132)*
Arm-foot pressure differential test
(mm Hg) 31 1 (0-7) 16 1 (0-8)*
Reactive hyperemia (mm Hg) 30 5 (0-16) 15 6 (2-20)*
Obstruction grade 33 1 (1-4) 18 1 (1-4)*
Airplethysmography
VFI90 (mL/min) 34 2.4 (0.9-11.9) 16 2.0 (0.1-7.2)*
Venous volume (mL) 33 67 (26-308) 17 77 (26-135)*
Ejection fraction (%) 33 57 (14-100) 17 41 (17-100)*
Residual volume fraction (%) 33 35 (0-82) 17 38 (0-100)*
Duplex scan examination
Multisegment reflux score12 36 2.5 (0-4) 18 2 (0-4)*
Descending venography
Kistner reflux grade12 36 0 (0-4) 18 0.5 (0-4)*
*P  not significant.
†P  .01.
‡P  .001.
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16 mm to 14 mm) could be avoided with the larger sized
stent to cover the entire length but dilate the smaller
luminal area with a balloon of appropriate smaller size.
A completion venogram was performed to assess in-
flow, flow velocity, outflow, and collateral status. IVUS
examination was an invaluable tool during all phases of the
procedure to confirm the nature and extent of present
pathology; to identify webs, membranes, and trabeculae
that could be masked in venography; to gauge transmural
changes to aid extension of the stent into normal areas at
either end; and to detect technical defects in stent deploy-
ment, such as shelving, separation, incomplete expansion,
and intrastent defects, such as flaps and thrombi. IVUS was
superior to venography in all these areas8-10 and reduced
the overall contrast load.
Perioperative anticoagulation therapy. Patients on
warfarin therapy were instructed to stop the medication 2
days before the intervention, and it was restarted again the
same day after the procedure. A preoperative international
normalized ratio of up to 2.7 was no contraindication to
the procedure. Dalteparin sodium (5000 units) was given
twice daily subcutaneously for 36 to 48 hours starting at the
time of preoperative sedation. Intravenous heparin (2000
to 5000 units) was administered after placement of the
sheath in the femoral vein. A synthetic nonsteroidal prepa-
ration (Toradol, American Regent Laboratory, Shirley, NY;
30 mg) was given at the time of recanalization and contin-
ued at 8 hourly intervals until discharge the next day. In
recent cases not included in this series, the latter drug was
replaced by IIbIIIa platelet inhibitor (abciximab; 15 mg)
given as a slow bolus intravenously at the time of recanali-
zation. All patients were discharged with aspirin (81 mg)
therapy daily or twice weekly if they were receiving warfarin
as well. Patients with homocystinemia (three patients) were
placed on aspirin, vitamin B6, and folate therapy but not
warfarin therapy. Warfarin therapy was instituted/reinsti-
tuted in all cases of thrombophilia (14 patients) and recur-
rent thromboembolism (six patients) and for other indica-
tions (two patients).
Data collection and statistics. Clinical data were
entered prospectively into a time-stamped electronic med-
ical records program and analyzed later. Nonparametric
Wilcoxin rank test for paired data, 2 analysis, and actuarial
curves (Kaplan-Meier) were used for statistical analysis as
appropriate. A commercially available statistical program
(Graph Pad Prism for Windows, version 3.0, GraphPad
Software, San Diego, Calif) was used for analysis.
RESULTS
Eight technical failures (8/46 limbs or 13%) occurred
and are excluded from the analysis presented here; their
clinical status remained unchanged after the failed attempt.
Five of these eight had closed or open prior interventions/
trauma of the occluded segment (two failed Palma by-
passes, two caval filter placements, one previous chronic self
drug administration). However, seven other limbs with
prior surgical intervention in the area were successfully
recanalized and are included in the series, indicating that
prior interventions diminished but did not preclude tech-
nical success. Among the 38 limbs included here, four
(4/38; 11%) had unsuccessful first attempt at recanaliza-
tion but had technical successes during subsequent at-
tempts (one on the third attempt), indicating that repeat
attempts in case of initial failure are worthwhile. No proce-
dure-related mortality or morbidity was seen. Mild to mod-
erate back pain for a few days after the procedure was
frequent and was readily controlled with nonnarcotic anal-
gesics in most patients. No infections or thromboses were
noted in connection with the use of extraluminal tampon-
ade device (Vasoseal).
Seventeen patients (45%) in this series had identifiable
hypercoagulable abnormalities: antithrombin III deficiency
in one patient, protein C deficiency in one patient, protein
S deficiency in one patient, both protein C and S deficiency
in two patients, factor V mutation in four patients, both
factor V and prothrombin mutations in one patient, lupus
anticoagulant in two patients, immunoglobulin M anticar-
diolipin antibody in one patient, immunoglobulin G anti-
cardiolipin antibody in one patient, homocystinemia in one
patient, and homocystinemia with abnormal homocysteine
gene in two patients. No correlation was seen between stent
patency and hypercoagulability. The median recanalized
segment length was nearly a foot long; median length of
stents was 22 cm (range, 2 to 27 cm). Multiple stents were
necessary in most limbs (36/38; median, 3; range, 1 to 6).
The stent was extended into the vena cava in all but one
limb in this series. In nine of 38 patients, the stent extended
well into the vena cava because the inferior vena cava
segment was occluded in continuity with the iliac vein; in
two of these cases, previously placed filters were pushed
aside with balloon dilation and a stent was placed astride
(Fig 2). In two limbs, the entire vena cava was occluded and
the stent extended to the right atrium (Fig 3). No adverse
renal or visceral outflow problems were noted in these
cases. In 28 limbs, the stent was extended for a short
distance into the inferior vena cava for technical reasons
(see Technique section); in only one of 38 limbs was the
stent not extended into the vena cava because the occlusive
lesion was confined to the external iliac vein.
In most limbs (74% or 28/38 limbs), the stent had to
be extended below the inguinal ligament to support a
stenotic/occluded common femoral vein segment. Stent
patency appeared to be unrelated to crossing the groin
crease; however, the overall number of occluded stents in
this series (n  7) was too small to draw valid conclusions
regarding these and other factors mentioned previously
that could affect stent patency.
Collaterals were documented in 36 of 38 limbs on table
preprocedure venography. After balloon dilation and stent
placement, collaterals had disappeared in 33 cases (Fig 4),
indicating that the stents had provided a lower resistance
alternative pathway for venous outflow; collaterals were less
prominent in the remaining three. Intraoperative pressure
measurements were significantly improved after recanaliza-
tion (Table II). Base femoral vein pressure, pressure gradi-
ent, and femoral vein pressure increase with papaverine
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hydrochloride6 each improved at least 3 mm Hg or more
after stent placement in 11/29, 11/23, and 10/27 limbs,
respectively. Postoperative functional tests, however, failed
to reflect these hemodynamic improvements (Table II).
Venographic follow-up was obtained in 29 of 38 pa-
tients at a median of 4 months (range, 2 to 23 months) after
recanalization. Two early (30 days) occlusions and five
late occlusions occurred. Thrombolysis was attempted but
failed in one of the two early occlusions. The two stents
deployed bestride a previous caval filter in two limbs were
venographically patent at 5 months and 1 year. Two pa-
tients with extension of the stent to the right atrium also
have maintained patency per venogram at 4 months and 1
year. Eight of a total of nine caval stents placed for recana-
lization of abdominal vena cava were patent at follow-up
venography; the single patient with the occluded caval stent
in this category had surprisingly minimal symptoms after
stent closure.
Among the 22 patent stents, preventive interventions
were undertaken in four cases (three symptomatic, one
asymptomatic) to correct partial thrombus/intimal hyper-
plasia in three limbs and stenosis distal to the stent in one
limb, respectively. Actuarial venographic primary, assisted
primary, and secondary patency rates (49%, 62%, and 76%,
Fig 2. A, When stent is extended into vena cava during recanalization, stent in contralateral limb can be placed side
by side in cava if there is room. Note Greenfield filter encased in occluded caval segment that was pushed aside with
balloon dilation during recanalization. Progressive dilatation was necessary to break cicatrix encasing filter. Balloon
puncture, although it occurred during this maneuver, was not a major problem. B, Alternative technique of fenestration
of previously placed stent in vena cava with balloon to configure two stents in form of inverted “Y.” This technique may
be used when enough room in cava is not present to place two stents side by side.
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respectively) at 24 months are shown in Fig 5. Clinical
follow-up was available in 32 of 38 patients (median, 11
months; range, 1 to 42 months).
Median pain level decreased significantly (P  .0001)
from a median preoperative level of 4 (range, 0 to 9) to a
postoperative level of 0 (range, 0 to 8) on the visual
analogue scale. Pain was a near universal feature before
surgery; only four of 32 or 11% had no pain. Most of the
patients (24/32 or 75%) were completely relieved of pain
after stent placement (P  .002).
Swelling decreased significantly (P  .004) from a
median preoperative clinical grade of 1 (range, 0 to 3) to a
postoperative grade of 0 (range, 0 to 3). No swelling was
seen in 22% (8/32) before surgery, which increased to 52%
(17/32) after surgery; this was significant (P  .02).
Stasis dermatitis/ulcers. Follow-up was available in
14 of 16 limbs with preoperative active ulcers (12/14) or
stasis dermatitis (2/2). Seven of 12 ulcers had healed, three
improved, and two were unchanged. The two limbs with
stasis dermatitis resolved. Actuarial complete healing of
stasis ulcers/dermatitis at 12 months was 66%.
Quality of life. Significant improvement was seen
(n  26) in pain (P  .002) and sleep criteria (P  .02),
nonsignificant improvement was seen in work (P .07, not
signifiant; 12 patients were retired for age before stent), and
no improvement was seen in morale and social activities.
DISCUSSION
Even for a short-term follow-up study, the patency rate
of recanalized previously occluded segments is remarkable,
given the circumstances widely perceived to be adverse to
stent patency: the long length of recanalized segments,
extension below the inguinal ligament in most patients, the
high incidence rate of hypercoagulability in the study co-
hort, and the use of minimal antithrombotic measures in
others. Despite common usage of terminology suggesting
nontraumatic correction (“angioplasty”), balloon dilation
of occluded segments remains a crude and uncontrolled
technique with likely fracture of the fibrous cord replacing
the thrombosed vein. Undoubtedly, some portions of the
stent were exposed bare in the retroperitoneum through
channel fractures. Yet there was no detectable retroperito-
neal bleeding and the patency rate was high. Details of the
reparative process with retention of stent patency in such a
high proportion of patients remain unknown. Biologic
compatibility of the stent material probably plays a signifi-
cant role. The use of an adjunctive arteriovenous fistula
with its potential for distal venous hypertension would
seem to be unnecessary given the high stent patency rate
without it.
Some technical points that we considered important
from our experience differ from current practice elsewhere
and are of note. The thigh approach with ultrasound scan
guidance has been associated with low access-related com-
plications in our experience (1%; n  525). We consid-
ered either 14 or 16 mm the optimal size for stents to be
placed in the iliac system. This was based on the normal size
of the healthy adult vein, the frequent occlusion of smaller
(12 or 10 mm) stents placed in the area by others in our
own institution, and the belief that the implant size should
Fig 3. Entire abdominal inferior vena that was occluded in continuity with common iliac vein was recanalized with
stent extending up to right atrium. No visceral or renal compromise was noted before or after stent placement, with
follow-up now extending more than 1 year.
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allow for some extra room for thrombus lining or intimal
hyperplasia that may occur with time. After a high inci-
dence rate of rapid ostial stenosis development at the iliac-
caval junction when the stent was restricted to the iliac
vein,9 we made a routine practice of extending the stent for
2 to 3 cm into the cava, eliminating this problem. In more
than 500 stent implantations, contralateral flow compro-
mise has not been a significant problem with this practice,
even in cases of ipsilateral stent occlusion (Fig 6). Our
earlier conservatism in tending to choose the shortest stent
length possible led to development of stenotic lesions in
partially diseased adjacent venous segments. This led to a
policy of a more aggressive approach of covering all contig-
uous diseased segments without short skip areas if practical.
Fig 4. Collaterals disappeared on contrast venography after recanalization in 33 of 36 limbs. An example is shown
above.
Fig 5. Actuarial primary (49%), assisted primary (62%), and secondary (76%) patency rates of stents after recanaliza-
tion at 2 years. Limbs at risk at each time interval are shown below curves. Standard error was0.12 or better at all data
points.
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Most stents have been extended to the common femoral
vein to satisfy this principle. Stent fracture or wall erosion
(false aneurysm, arteriovenous fistula) was not seen in this
experience. Crossing the inguinal ligament (Fig 7) appears
not to have had an adverse effect on stent patency, at least in
the short term. This is probably related to the exclusive use
of flexible stents that can bend without lumen compromise.
We have not placed stents in the superficial femoral vein
because the profunda femoris vein provides adequate in-
flow and the reported experience of superficial femoral vein
stent placement has been relatively poor.11
The clinical efficacy of recanalization with stent place-
ment in this subset of patients with advanced iliac venous
disease has been impressive despite the presence of signifi-
cant distal obstruction and reflux. It underscores the dom-
inant role of the iliac venous segment in the genesis of
postthrombotic syndrome. Complete pain resolution oc-
curred in most patients, with significant improvement in
others. The analogue scale technique used in this report,
although subjective, is widely used and has been validated4
as a reliable standard in outcome measurement.
Swelling results in this study are understated. For ex-
ample, three patients became ambulatory from previous
wheelchair confinement, and in others, whole limb swelling
receded to more limited swelling below the knee after
recanalization. Yet the objective classification of limb swell-
ing remained the same (grade 3) before and after the stent
placement and the swelling outcome was marked as un-
changed. Total resolution of swelling did occur in about a
third of patients after recanalization. Actuarial healing of
ulcers/stasis dermatitis in 66% at 1 year was noteworthy
because stasis skin changes and ulceration are generally
attributed to reflux not obstruction. Uncorrected residual
reflux (multisegment12) (Table II) persisted in these limbs
after the stent procedure.
Of note, swelling was absent in 22% of the patients
despite occluded iliac veins. Some patients were first seen
with pain alone without any other outward signs of iliac
occlusion; clinical features in others would have suggested
reflux, not obstruction (Table I). This varied and some-
times deceptive presentation masking the underlying iliac
venous occlusion argues for comprehensive investigation of
patients without preconceived notions regarding underly-
ing pathology. Duplex scan is being increasingly used both
as a screening and a sole diagnostic technique in chronic
venous insufficiency. It is not well suited to assessment of
Fig 6. Extension of stent for 2 to 3 cm into cava prevents stenosis
development at iliocaval junction after recanalization and does not
impede contralateral outflow as shown.
Fig 7. Crossing inguinal ligament or long stent length did not
appear to affect patency. Note long stent extending from common
femoral vein to mid inferior vena cava.
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the iliac venous segment, and an occlusive or stenotic lesion
is easily missed.
Clinical efficacy, disappearance of collaterals, and im-
provement in intraoperative femoral vein pressures (Table
II) indicate that tangible hemodynamic benefit resulted
from the stent procedure. Yet this was not reflected in any
of the postoperative functional studies, including arm/foot
venous pressure differential, undertaken in this group of
patients (Table II). The latter test has been considered the
most reliable among the currently available tests for venous
obstruction.13 Outflow fraction measurements are even less
reliable.14-16 We conclude that all functional tests of ob-
struction currently available lack sensitivity. It was of note,
however, that reflux as measured with venous filling in-
dex90 (VFI90) with airplethysmography and multisegment
reflux score12with duplex scan did not worsen after recan-
alization (Table II). Chronic iliac venous occlusion was not
“protective” of reflux, and opening up the axial channel did
not lead to a worsening.
The median follow-up time frame for this series of
patients was 11 months. In the smaller number of patients
followed up to 3 years or more, clinical efficacy and stent
patency appear to have been maintained without signs of
precipitous deterioration. Reported experience with veno-
venous bypass procedures had been highly variable with
regard to bypass patency and clinical efficacy16-18; in several
such series, the results had declined below those reported
here for stents at a comparable time frame. The high
technical and clinical success of stent technology as used in
this study and its relative simplicity (percutaneous proce-
dure, 23-hour admit) would appear to render traditional
open venovenous bypass techniques obsolete except as a
backup procedure in patients with failed stent placement.
Placement of stents does not preclude subsequent open
technique in case of stent failure.
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